Form 4 for CCCC C4 Therapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001209191-21-059512 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-05 | 2021-10-01 | CCCC | Crystal Adam | Chief Medical Off | S - Sale+OE | $45.43 | -15.0K | 0 | -100% | -$681.4K |
| D | 2021-10-05 | 2021-10-01 | CCCC | Crystal Adam | Chief Medical Off | M - OptEx | $4.98 | +15.0K | 15.0K | New | +$74.7K |
| D | 2021-10-05 | 2021-10-01 | CCCC | Crystal Adam | Chief Medical Off | M - OptEx | $0.00 | -15.0K | 168.1K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | S | D | 8,176 | $45.32 | 5,112 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $44.85 to $45.845. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-10-01 | S | D | 1,712 | $44.25 | 13,288 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $43.57 to $44.56. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-10-01 | S | D | 5,112 | $45.99 | 0 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.89 to $46.30. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-10-01 | M | A | 15,000 | $4.98 | 15,000 | D | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2021-10-01 | M | D | 15,000 | $0.00 | 168,108 | D | $4.98 · — to 2030-07-02 | 15,000 Common Stock | (F5) This option shall vest and become exercisable in 20 equal quarterly installments, with the first installment vesting on September 5, 2020. |